Edgestream Partners’s Insmed INSM Stock Holding History

Edgestream Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$409K	Sell	2,499 -1,617	-39%	-$249K	0.01%	763
2025 Q4	$716K	Buy	+4,116	New	+$751K	0.02%	750
2025 Q3	–	Sell	-4,265	Closed	-$429K	–	970
2025 Q2	$429K	Buy	+4,265	New	+$326K	0.01%	751
2025 Q1	–	Sell	-43,619	Closed	-$3.01M	–	934
2024 Q4	$3.01M	Buy	43,619 +40,369	+1,242%	+$2.91M	0.13%	310
2024 Q3	$237K	Sell	3,250 -4,805	-60%	-$355K	0.01%	791
2024 Q2	$540K	Buy	+8,055	New	+$312K	0.03%	656
2024 Q1	–	Sell	-11,758	Closed	-$364K	–	911
2023 Q4	$364K	Buy	+11,758	New	+$305K	0.03%	675
2022 Q4	–	Sell	-73,982	Closed	-$1.59M	–	564
2022 Q3	$1.59M	Buy	73,982 +11,651	+19%	+$279K	0.12%	223
2022 Q2	$1.23M	Buy	62,331 +18,804	+43%	+$394K	0.1%	282
2022 Q1	$1.02M	Sell	43,527 -79,410	-65%	-$1.85M	0.08%	325
2021 Q4	$3.35M	Sell	122,937 -62,578	-34%	-$1.79M	0.21%	146
2021 Q3	$5.11M	Sell	185,515 -176,816	-49%	-$4.64M	0.32%	105
2021 Q2	$10.3M	Buy	+362,331	New	+$10.8M	0.61%	37

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Edgestream Partners's INSM Position: Q1 2026 in Review

Edgestream Partners reduced its Insmed (INSM) stake by 39% in Q1 2026, selling an estimated $249K and leaving 2,499 shares worth $409K. The position accounts for 0.01% of the portfolio, ranked #763.

Edgestream Partners first reported a position in INSM in Q2 2021 and has held it in 13 quarters since. The position peaked at $10.3M in Q2 2021. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Edgestream Partners held 2,499 shares of Insmed worth $409K as of Q1 2026.
Edgestream Partners sold 1,617 Insmed shares in Q1 2026, an estimated $249K.
Insmed made up 0.01% of Edgestream Partners's portfolio in Q1 2026, its #763 holding.
Edgestream Partners first reported a position in Insmed in Q2 2021 and has held it in 13 quarters since.
Edgestream Partners's Insmed position peaked at $10.3M in Q2 2021.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.